Bausch Health
BHC
#3383
Rank
C$4.77 B
Marketcap
$12.99
Share price
-0.85%
Change (1 day)
37.55%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Revenue for Bausch Health (BHC)

Revenue in 2023 (TTM): C$2.16 Billion

According to Bausch Health 's latest financial reports the company's current revenue (TTM ) is C$13.17 Billion. In 2022 the company made a revenue of C$11.02 Billion an increase over the revenue in the year 2021 that were of C$10.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bausch Health from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) C$2.16 B-80.34%
2022 C$11.02 B2.56%
2021 C$10.74 B5.02%
2020 C$10.23 B-8.89%
2019 C$11.23 B-1.59%
2018 C$11.41 B4.08%
2017 C$10.96 B-15.63%
2016 C$12.99 B-10.11%
2015 C$14.46 B50.81%
2014 C$9.58 B56.14%
2013 C$6.14 B74.15%
2012 C$3.52 B40.74%
2011 C$2.50 B112.22%
2010 C$1.18 B36.78%
2009 C$0.86 B-6.23%
2008 C$0.92 B9.5%
2007 C$0.84 B-31.99%
2006 C$1.23 B13.35%
2005 C$1.09 B2.67%
2004 C$1.06 B-0.58%
2003 C$1.06 B-14.15%
2002 C$1.24 B33.95%
2001 C$0.92 B97.58%
2000 C$0.47 B87.26%
1999 C$0.25 B44.67%
1998 C$0.17 B47.44%
1997 C$0.11 B29.81%
1996 C$90.69 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$0.31 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.99 B-92.44%๐Ÿ‡บ๐Ÿ‡ธ USA